Skin Cancer â Squamous Cell Carcinoma (SCC)
Overview
Squamous cell carcinoma (SCC) of the skin is the secondâmost common form of nonâmelanoma skin cancer, arising from the squamous cells that make up the outer layer of the epidermis. While it accounts for only about 15â20âŻ% of all skinâcancer cases, it is more likely than basal cell carcinoma (the most common type) to spread (metastasize) to deeper tissues or other organs if left untreated.
Who it affects: Anyone can develop SCC, but it is most prevalent in adults agedâŻ50âŻyears and older. Men are slightly more likely than women to be diagnosed, and the incidence is highest among people with fair skin (e.g., types IâII on the Fitzpatrick scale) who have a history of intense or cumulative ultraviolet (UV) exposure.
Prevalence: In the United States, the American Cancer Society estimates ~700,000 new cases of nonâmelanoma skin cancer each year, with SCC representing roughly 100,000â150,000 of those. The incidence is rising worldwide, largely due to increased UV exposure and aging populations (CDC, American Cancer Society).
Symptoms
SCC can appear on any sunâexposed area, but the most common sites are the face, ears, neck, lips, dorsum of the hands, and arms. Early lesions may be painless and easily overlooked.
- Persistent, scaly patch â Often looks like a rough, red or brown patch that does not heal.
- Raised, fleshâcolored or pink bump â May have a central ulcer or crust. Ulcerated lesion â An open sore that bleeds or oozes and does not improve with typical wound care.
- Red or pink growth with a warty surface â Sometimes described as âwartâlike.â
- Hard, thickened area (keratotic plaque) â Can feel âleathery.â
- Growth that spreads outward â Edges may be poorly defined or ârolled.â
- Changes in an existing scar or burn â A new lump or ulceration developing in a previously injured area (Marjolin ulcer).
- Bleeding or crusting â Especially after minor trauma.
- Pain or tenderness â Usually a late sign when the tumor invades nerves.
If any skin lesion changes in size, shape, color, or texture, or fails to heal within 2â4âŻweeks, it should be evaluated by a clinician.
Causes and Risk Factors
Squamous cell carcinoma is primarily driven by DNA damage to skin cells from ultraviolet radiation, but several other factors contribute.
Primary Causes
- Ultraviolet (UV) radiation â Both UVA (aging) and UVB (burning) wavelengths cause mutations in theâŻp53 tumorâsuppressor gene.
- Human papillomavirus (HPV) infection â Certain highârisk subtypes (e.g., HPV 16, 31) are linked to SCC of the anogenital region and, less commonly, the skin.
Risk Factors
- Fair skin, red or blond hair, blue/green eyes â Low melanin provides less natural UV protection.
- Chronic sun exposure â Outdoor occupations (farmers, construction workers) and recreational exposure (beach, skiing).
- History of severe sunburns, especially in childhood.
- AgeâŻâ„âŻ50âŻyears â Cumulative DNA damage over time.
- Immunosuppression â Organâtransplant recipients, HIV infection, chronic corticosteroid use; risk can be 65âfold higher.
- Previous skin cancers â Basal cell carcinoma or SCC increases future risk.
- Chronic wounds, scars, burns, or inflammatory skin conditions â e.g., actinic keratoses, lupus, lichen planus.
- Exposure to arsenic or certain chemicals â Occupational exposure to tar, coalâtar, or petroleum products.
- Female genital or perianal SCC â Linked to HPV.
Diagnosis
Early detection improves outcomes dramatically. Diagnosis typically proceeds through a stepwise approach.
Clinical Evaluation
- History and visual exam â Dermatologist notes size, color, border, texture, and location.
- Dermatoscopy â A handheld magnifier that reveals vascular patterns and surface features suggestive of SCC.
Biopsy Procedures
Definitive diagnosis requires a tissue sample.
- Punch biopsy â Removes a core of skin (2â6âŻmm) and is suitable for most lesions.
- Excisional biopsy â Entire lesion is removed; preferred for small, wellâdefined tumors.
- Shave biopsy â Thin slice of superficial tissue; may be used for flat lesions but can miss deeper invasion.
Pathology
Pathologists assess for atypical squamous cells, keratin pearls, and invasion depth (Breslow thickness). They also grade the tumor (wellâ, moderatelyâ, or poorlyâdifferentiated) and look for perineural involvement.
Staging & Imaging
Staging follows the AJCC (American Joint Committee on Cancer) 8th edition.
- Highârisk features (sizeâŻ>âŻ2âŻcm, deep invasion >âŻ2âŻmm, perineural invasion, poor differentiation) may warrant imaging such as ultrasound, CT, or MRI to assess nodes or metastasis.
- Sentinel lymph node biopsy â Considered for tumors with high metastatic potential.
Treatment Options
Treatment is individualized based on tumor size, location, depth, patient health, and cosmetic considerations.
Surgical Interventions
- Excisional surgery â Standard of care for most SCCs; removes tumor with 4â6âŻmm margins (wider for highârisk lesions).
- Mohs micrographic surgery â Tissue is removed layerâbyâlayer, examined in real time. Offers highest cure rates (up to 99âŻ% for facial SCC) and preserves healthy tissue.
- Curettage & electrodesiccation â Scraping the lesion followed by cauterization; used for small, lowârisk tumors.
NonâSurgical Treatments
- Radiation therapy â External beam radiation for patients who cannot undergo surgery or for incompletely excised lesions.
- Topical agents â 5âFluorouracil (5âFU) or imiquimod may treat superficial SCC in situ (Bowen disease).
- Cryotherapy â Freezing with liquid nitrogen; effective for tiny, wellâdefined lesions.
- Photodynamic therapy (PDT) â Photosensitizing agent + light activation; suitable for superficial SCC.
Systemic Therapies (Advanced/Metastatic SCC)
- Immune checkpoint inhibitors â Cemiplimab (PDâ1 inhibitor) and pembrolizumab have shown durable responses in metastatic or locally advanced SCC (NIH).
- Targeted therapy â EGFR inhibitors (cetuximab) may be used in select cases.
- Chemotherapy â Platinumâbased regimens (cisplatin + 5âFU) for patients not eligible for immunotherapy.
Lifestyle & Supportive Measures
- Wound care after surgery (clean dressings, infection prevention).
- Smoking cessation â smoking impairs wound healing and is a known risk factor.
- Regular skin examinations â selfâchecks and professional visits.
Living with Skin Cancer â Squamous Cell Carcinoma
Managing SCC after treatment involves vigilance, skin protection, and emotional support.
Daily Skin Care
- Use a broadâspectrum sunscreen (SPFâŻ30âŻor higher) daily; reapply every 2âŻhours when outdoors.
- Wear protective clothing, wideâbrim hats, and UVâblocking sunglasses.
- Avoid tanning beds and seek shade between 10âŻamâ4âŻpm.
- Inspect your skin every morning and night; use a mirror or ask a partner to check hardâtoâsee areas.
Followâup Schedule
Most dermatologists recommend:
- First postoperative visit within 1â2âŻweeks.
- Subsequent visits every 3â6âŻmonths for the first 2âŻyears, then annually.
Bring any new or changing lesions to the appointment.
Psychosocial Wellâbeing
- Join support groups (e.g., Skin Cancer Foundation community).
- Consider counseling if you experience anxiety about recurrence or cosmetic concerns.
- Maintain a balanced diet rich in antioxidants (fruits, vegetables) to support immune health.
Prevention
Prevention focuses on reducing UV exposure and early detection.
SunâSafety Practices
- Apply sunscreen 15âŻminutes before going outside; use at least 1âŻounce (a shotâglass full) for full body.
- Choose âbroadâspectrumâ labeled products (protect against UVA and UVB).
- Wear UPFâŻ50+ clothing, especially for outdoor work.
- Seek shade whenever possible.
Behavioral Modifications
- Stop smoking â it increases skinâcancer risk and hampers healing.
- Limit use of photosensitizing medications (e.g., tetracyclines, thiazide diuretics) after discussing alternatives with your doctor.
- Regularly treat actinic keratoses (precancerous lesions) with cryotherapy or topical agents to prevent progression.
Screening Recommendations
- AdultsâŻâ„âŻ35âŻyears with a history of extensive sun exposure should have a fullâbody skin exam by a dermatologist every 1â2âŻyears.
- Highârisk groups (organâtransplant recipients, immunosuppressed, prior SCC) need exams every 6â12âŻmonths.
Complications
If SCC is not treated promptly, several serious complications can arise.
- Local invasion â Tumor can erode into muscle, cartilage, bone, or underlying organs, especially on the nose, ear, or lip.
- Perineural spread â Cancer tracks along nerves, causing pain, numbness, or facial muscle weakness.
- Regional lymphânode metastasis â Approximately 5â10âŻ% of SCCs spread to nearby nodes; associated with a 5âyear survival <âŻ70âŻ%.
- Distant metastasis â Rare (<1â2âŻ%) but can affect lungs, liver, brain, or bone.
- Functional and cosmetic deficits â Large resections may require reconstructive surgery, affecting speech, vision, or appearance.
- Psychological impact â Anxiety, depression, or bodyâimage issues after treatment.
When to Seek Emergency Care
- Rapidly enlarging or ulcerating lesion that bleeds profusely.
- Severe pain, swelling, or numbness around a known SCC, suggesting infection or perineural invasion.
- Fever, chills, or red streaks spreading from the site â signs of cellulitis or sepsis.
- Difficulty breathing, swallowing, or speaking because a tumor on the neck or throat is obstructing the airway.
- Sudden, unexplained weight loss or new lumps in the neck (possible lymphânode spread).
Prompt medical attention can prevent lifeâthreatening complications.
Sources:
- Mayo Clinic. âSquamous cell skin cancer.â https://www.mayoclinic.org
- American Cancer Society. âSkin Cancer Facts & Figures.â 2024. https://www.cancer.org
- CDC. âNonâmelanoma Skin Cancer.â 2023. https://www.cdc.gov
- National Institutes of Health. âCemiplimab for advanced cutaneous squamous cell carcinoma.â 2022. https://www.ncbi.nlm.nih.gov
- Cleveland Clinic. âSquamous Cell Skin Cancer.â 2024. https://my.clevelandclinic.org
- World Health Organization. âUltraviolet radiation and the skin.â 2021. https://www.who.int